AI Buyer Insights:

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Collgard Biopharmaceuticals Data, Technology Stack, and Enterprise Applications
CyberSecurity
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Link11 Legacy DOSarrest DDoS Protection CyberSecurity n/a 2023 2023
IT Decision Makers and Key Stakeholders at Collgard Biopharmaceuticals
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Collgard Biopharmaceuticals Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Collgard Biopharmaceuticals Technographics

Collgard Biopharmaceuticals is a Life Sciences organization based in United States, with around 10 employees and annual revenues of $1.0 million.

Collgard Biopharmaceuticals operates a diverse technology stack with applications such as DOSarrest, covering areas like DDoS Protection.

Collgard Biopharmaceuticals has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Link11.

Collgard Biopharmaceuticals recently adopted applications including DOSarrest in 2023, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Collgard Biopharmaceuticals’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Collgard Biopharmaceuticals’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Collgard Biopharmaceuticals technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.